BioSpace News Archive

Photocure ASA reported Hexvix®/Cysview® revenues of NOK 115.9 million in the second quarter of 2023, and an EBITDA of NOK 23.4 million.

Anteris Technologies Ltd, reported that it has established a sponsored Level 1 American Depository Receipt program in the United States.

BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today reported financial results and provided a business update for the second quarter ended June 30, 2023.

Antion Biosciences SA proudly announces the appointment of John Tchelingerian, PhD, a veteran of the biotech industry, as the new Chairman of its Board of Directors.

Mallinckrodt plc, a global specialty pharmaceutical company, reported results for the second quarter ended June 30, 2023.1

Form Bio , the breakthrough AI-powered drug discovery platform, announced today its notable achievements and product advancements for the first half of 2023.

Olink Holding AB announced its unaudited financial results for the second quarter ended June 30, 2023.

Jnana Therapeutics today announced that the first participant has been dosed in its Phase 1b clinical trial of JNT-517 in individuals with phenylketonuria (PKU). JNT-517 is a small molecule inhibitor of the phenylalanine (Phe) transporter SLC6A19 and is in development as a potential first-in-class oral treatment for PKU.

Virios Therapeutics, Inc. today announced that the Food & Drug Administration (“FDA”) communicated that, following their initial review of the Company’s chronic toxicology program, the program’s studies appear adequate to support the safety of IMC-1 at the dose proposed by the Company for chronic use.

Medunik USA (member of Duchesnay Pharmaceutical Group) is pleased to announce that an increasing number of Americans with certain urea cycle disorders (UCDs) now have access to Pheburane® (sodium phenylbutyrate) through a rapidly expanding network of key pharmacy benefit managers (PBMs), state Medicaid programs or Managed Medicaid plans.